Editorial: The intertwisted correlations among non-alcoholic fatty liver disease, atherosclerosis, and metabolic syndrome

Journal of Gastroenterology

Volumn 44, Issue 11, 2009, Pages 1162-1164

  Nakao, Haruhisa ^a   Yoneda, Masashi ^a  

^a AICHI MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; GAMMA GLUTAMYLTRANSFERASE;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTERY INTIMA PROLIFERATION; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; ATHEROSCLEROSIS; CARDIOVASCULAR RISK; CAROTID ARTERY DISEASE; DISEASE ASSOCIATION; DYSLIPIDEMIA; EDITORIAL; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; HUMAN; INFLAMMATION; INSULIN RESISTANCE; METABOLIC SYNDROME X; NON INSULIN DEPENDENT DIABETES MELLITUS; NONALCOHOLIC FATTY LIVER; OBESITY; OXIDATIVE STRESS; PRIORITY JOURNAL; CARDIOVASCULAR DISEASE; FATTY LIVER; LIVER FUNCTION TEST; NOTE; PATHOPHYSIOLOGY; RISK FACTOR;

ATHEROSCLEROSIS; CARDIOVASCULAR DISEASES; CAROTID ARTERY DISEASES; DIABETES MELLITUS, TYPE 2; FATTY LIVER; HUMANS; LIVER FUNCTION TESTS; METABOLIC SYNDROME X; RISK FACTORS;

EID: 73449133336     PISSN: 09441174     EISSN: 14355922     Source Type: Journal    
DOI: 10.1007/s00535-009-0140-9     Document Type: Editorial

References (27)

1. P Angulo 2002 Nonalcoholic fatty liver disease N Engl J Med 346 1221 1231 10.1056/NEJMra011775 1:CAS:528:DC%2BD38XivVOmsrY%3D 11961152 (Pubitemid 34984585)
2. R Williams 2006 Global challenges in liver disease Hepatology 44 521 526 10.1002/hep.21347 16941687 (Pubitemid 44433707)
3. G Targher 2007 Non-alcoholic fatty liver disease, the metabolic syndrome and the risk of cardiovascular disease: the plot thickens Diabet Med 24 1 6 10.1111/j.1464-5491.2007.02025.x 1:STN:280:DC%2BD2s%2FmsVWgsw%3D%3D 17227317 (Pubitemid 46103064)
4. LA Adams P Angulo 2005 Recent concepts in non-alcoholic fatty liver disease Diabet Med 22 1129 1133 10.1111/j.1464-5491.2005.01748.x 1:CAS:528:DC%2BD2MXhtVOlt77E 16108837 (Pubitemid 41224168)
5. M Hamaguchi T Kojima N Takeda T Nakagawa H Taniguchi K Fujii, et al. 2005 The metabolic syndrome as a predictor of nonalcoholic fatty liver disease Ann Intern Med 143 722 728 1:CAS:528:DC%2BD2MXht1yntLrN 16287793
6. G Marchesini M Brizi G Bianchi S Tomassetti E Bugianesi M Lenzi, et al. 2001 Nonalcoholic fatty liver disease: a feature of the metabolic syndrome Diabetes 50 1844 1850 10.2337/diabetes.50.8.1844 1:CAS:528:DC%2BD3MXlslKmsr4%3D 11473047
7. G Marchesini E Bugianesi G Forlani F Cerrelli M Lenzi R Manini, et al. 2003 Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome Hepatology 37 917 923 10.1053/jhep.2003.50161 12668987 (Pubitemid 36397405)
8. E Bonora G Targher G Formentini F Calcaterra S Lombardi F Marini, et al. 2004 The metabolic syndrome is an independent predictor of cardiovascular disease in type 2 diabetic subjects. Prospective data from the Verona Diabetes Complications Study Diabet Med 21 52 58 10.1046/j.1464-5491.2003.01068.x 1:STN:280:DC%2BD2c%2FgvFKqsg%3D%3D 14706054 (Pubitemid 38168029)
9. BA Neuschwander-Tetri 2005 Nonalcoholic steatohepatitis and the metabolic syndrome Am J Med Sci 330 326 335 10.1097/00000441-200512000-00011 16355018
10. G Marchesini R Marzocchi 2007 Metabolic syndrome and NASH Clin Liver Dis 11 105 117 10.1016/j.cld.2007.02.013 17544974 (Pubitemid 46829976)
11. Q Qiao W Gao L Zhang R Nyamdorj J Tuomilehto 2007 Metabolic syndrome and cardiovascular disease Ann Clin Biochem 44 232 263 10.1258/000456307780480963 17456293 (Pubitemid 351724689)
12. A Brea D Mosquera E Martin A Arizti JL Cordero E Ros 2005 Nonalcoholic fatty liver disease is associated with carotid atherosclerosis: a case-control study Arterioscler Thromb Vasc Biol 25 1045 1050 10.1161/01.ATV.0000160613. 57985.18 1:CAS:528:DC%2BD2MXjsVCjtL8%3D 15731489 (Pubitemid 40627853)
13. G Targher L Bertolini F Poli S Rodella L Scala R Tessari, et al. 2005 Nonalcoholic fatty liver disease and risk of future cardiovascular events among type 2 diabetic patients Diabetes 54 3541 3546 10.2337/diabetes.54.12.3541 1:CAS:528:DC%2BD2MXht12gsL%2FN 16306373 (Pubitemid 43334347)
14. DH O'Leary JF Polak 2002 Intima-media thickness: a tool for artherosclerosis imaging and event prediction Am J Cardiol 90 18 21 10.1016/S0002-9149(02)02957-0
15. Lorenz MW, Markus HS, Bots ML, Rosvall M, Sitzer M. Prediction of clinical cardiovascular events with carotid intima-media thickness: a systematic review and meta-analysis. Circulation 2007;115:459-67.
16. G Targher L Bertolini S Rodella R Tessari L Zenari G Lippi, et al. 2007 Nonalcoholic fatty liver disease is independently associated with an increased incidence of cardiovascular events in type 2 diabetic patients Diabetes Care 30 2119 2121 10.2337/dc07-0349 1:CAS:528:DC%2BD2sXpsleks7Y%3D 17519430 (Pubitemid 47219432)
17. G Targher L Bertolini R Padovani S Rodella G Zoppini L Zenari, et al. 2006 Relations between carotid artery wall thickness and liver histology in subjects with nonalcoholic fatty liver disease Diabetes Care 29 1325 1330 10.2337/dc06-0135 16732016 (Pubitemid 44125930)
18. S Sookoian C Prirola 2008 Non-alcoholic fatty liver disease is strongly associated with carotid atherosclerosis: a systematic review J Hepatol 49 600 607 10.1016/j.jhep.2008.06.012 18672311
19. H Volzke DM Robinson V Kleine R Deutscer W Hoffmann J Ludemann, et al. 2005 Hepatic steatosis is associated with an increased risk of carotid atherosclerosis World J Gastroenterol 11 1848 1853 15793879
20. C Carallo G Mancuso G Mauro F Laghi B Madafferi C Irace 2009 Hepatic steatosis, carotid atherosclerosis and metabolic syndrome: the STEATO study J Gastoroenterol 44 1156 1161 10.1007/s00535-009-0125-8
21. DJ Kim JH Noh NH Cho BW Lee YH Choi JH Jung, et al. 2005 Serum gamma-glutamyltransferase within its normal concentration range is related to the presence of diabetes and cardiovascular risk factors Diabet Med 22 1134 1140 10.1111/j.1464-5491.2005.01581.x 1:CAS:528:DC%2BD2MXhtVOlt7%2FM 16108838 (Pubitemid 41224169)
22. O Turgut A Yilmaz K Yalta F Karadas YM Birhan 2006 γ- Glutamyltransferase is a promising biomarker for cardiovascular risk Med Hypotheses 67 1060 1064 10.1016/j.mehy.2006.04.010 1:CAS:528: DC%2BD28XpsVKlt7w%3D 16891060 (Pubitemid 44302237)
23. CE Ruhl JE Everhart 2009 Elevated serum alanine aminotransferase and gamma-glutamyltransferase and mortality in the United States population Gastroenterology 136 477 485 10.1053/j.gastro.2008.10.052 1:CAS:528: DC%2BD1MXislOhtLo%3D 19100265
24. L Pacifico V Cantisani P Ricci JH Osborn E Schiavo C Anania, et al. 2008 Nonalcoholic fatty liver disease and carotid atherosclerosis in children Pediatr Res 63 423 427 10.1203/PDR.0b013e318165b8e7 1:CAS:528:DC%2BD1cXjt1eksbg%3D 18356751
25. JB Schwimmer PE Pardee JE Lavine AK Blumkin S Cook 2008 Cardiovascular risk factors and the metabolic syndrome in pediatric nonalcoholic fatty liver disease Circulation 118 277 283 10.1161/CIRCULATIONAHA.107.739920 1:CAS:528:DC%2BD1cXot1yis7w%3D 18591439
26. G Targher L Bertolini L Scala G Zoppini L Zenari G Falezza 2005 Non-alcoholic hepatic steatosis and its relation to increased plasma biomarkers of inflammation and endothelial dysfunction in non-diabetic men. Role of visceral adipose tissue Diabet Med 22 1354 1358 10.1111/j.1464-5491.2005.01646.x 1:CAS:528:DC%2BD2MXhtFGrt7bN 16176196 (Pubitemid 41391311)
27. Z Yesilova H Yaman C Oktenli A Ozcan A Uygun E Cakir, et al. 2005 Systemic markers of lipid peroxidation and antioxidants in patients with nonalcoholic fatty liver disease Am J Gastroenterol 100 850 855 10.1111/j.1572-0241.2005.41500.x 1:CAS:528:DC%2BD2MXktFart74%3D 15784031 (Pubitemid 40592378)